PD 0200390 Dose-ranging Trial: A Randomized, Double-blind, Placebo-controlled, 5-way Crossover, Multicenter Polysomnography Trial of PD 0200390 in Adults With Primary Insomnia.
Phase of Trial: Phase II
Latest Information Update: 24 Jul 2012
At a glance
- Drugs Atagabalin (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 02 Oct 2009 Actual patient number changed from 83 to 92 as reported by ClinicalTrials.gov.
- 17 Jul 2008 Actual end date (Jan 2008) added as reported by ClinicalTrials.gov.